193 related articles for article (PubMed ID: 11293903)
1. Realistic pathologic classification of acute myeloid leukemias.
Arber DA
Am J Clin Pathol; 2001 Apr; 115(4):552-60. PubMed ID: 11293903
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of acute myeloid leukemia classification. Importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival.
Arber DA; Stein AS; Carter NH; Ikle D; Forman SJ; Slovak ML
Am J Clin Pathol; 2003 May; 119(5):672-80. PubMed ID: 12760285
[TBL] [Abstract][Full Text] [Related]
3. [Diagnosis of myeloid hematologic malignancies: contributions of the 2001 World Health Organization (WHO) classification].
Leymarie V; Galoisy AC; Falkenrodt A; Lessard M
Ann Biol Clin (Paris); 2004; 62(5):513-20. PubMed ID: 15355801
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and classification of the acute leukemias: recent advances and controversial issues.
Taylor CG; Stasi R; Bastianelli C; Venditti A; Del Poeta G; Amadori S; Sargent J
Hematopathol Mol Hematol; 1996; 10(1-2):1-38. PubMed ID: 8792146
[TBL] [Abstract][Full Text] [Related]
5. Role of FAB classification of acute leukemias in era of immunophenotyping.
Sachdeva MU; Ahluwalia J; Das R; Varma N; Garewal G
Indian J Pathol Microbiol; 2006 Oct; 49(4):524-7. PubMed ID: 17183842
[TBL] [Abstract][Full Text] [Related]
6. [Haematological characteristics, FAB and WHO classification of 153 cases of myeloid acute leukaemia in Tunisia].
Braham-Jmili N; Sendi-Senana H; Labiadh S; Ben Abdelali R; Ben Abdelaziz A; Khelif A; Saad A; Kortas M
Ann Biol Clin (Paris); 2006; 64(5):457-65. PubMed ID: 17040877
[TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia.
Heerema-McKenney A; Arber DA
Hematol Oncol Clin North Am; 2009 Aug; 23(4):633-54. PubMed ID: 19577162
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric characterization of acute myeloid leukemia. Part 1. Significance of light scattering properties.
Terstappen LW; Könemann S; Safford M; Loken MR; Zurlutter K; Büchner T; Hiddemann W; Wörmann B
Leukemia; 1991 Apr; 5(4):315-21. PubMed ID: 2027298
[TBL] [Abstract][Full Text] [Related]
9. World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes.
Bernasconi P; Klersy C; Boni M; Cavigliano PM; Calatroni S; Giardini I; Rocca B; Zappatore R; Caresana M; Dambruoso I; Lazzarino M; Bernasconi C
Br J Haematol; 2007 May; 137(3):193-205. PubMed ID: 17408458
[TBL] [Abstract][Full Text] [Related]
10. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
11. Molecular evaluation of acute myeloid leukemias.
Willman CL
Semin Hematol; 1999 Oct; 36(4):390-400. PubMed ID: 10530720
[TBL] [Abstract][Full Text] [Related]
12. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
[TBL] [Abstract][Full Text] [Related]
13. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity.
Kozlov I; Beason K; Yu C; Hughson M
Cancer Genet Cytogenet; 2005 Nov; 163(1):62-7. PubMed ID: 16271957
[TBL] [Abstract][Full Text] [Related]
14. Acute leukemias: a paradigm for the integration of new technologies in diagnosis and classification.
Willman CL
Mod Pathol; 1999 Feb; 12(2):218-28. PubMed ID: 10071344
[TBL] [Abstract][Full Text] [Related]
15. A comparative review of classification systems in myelodysplastic syndromes (MDS).
Bennett JM
Semin Oncol; 2005 Aug; 32(4 Suppl 5):S3-10. PubMed ID: 16085011
[TBL] [Abstract][Full Text] [Related]
16. Therapy-related acute myeloid leukemia/myelodysplasia with balanced 21q22 translocations.
Arber DA; Slovak ML; Popplewell L; Bedell V; Ikle D; Rowley JD;
Am J Clin Pathol; 2002 Feb; 117(2):306-13. PubMed ID: 11863228
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein and multidrug resistance associated protein-1 activity in 132 acute myeloid leukemias according to FAB subtypes and cytogenetics risk groups.
Legrand O; Zompi S; Perrot JY; Faussat AM; Benderra Z; Chaoui D; Marie JP
Haematologica; 2004 Jan; 89(1):34-41. PubMed ID: 14754604
[TBL] [Abstract][Full Text] [Related]
18. Distinct cytogenetic and clinicopathologic features in acute myeloid leukemia after occupational exposure to pesticides and organic solvents.
Fagioli F; Cuneo A; Piva N; Carli MG; Previati R; Balboni M; Tomasi P; Cariani D; Scapoli G; Castoldi G
Cancer; 1992 Jul; 70(1):77-85. PubMed ID: 1606550
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic, morphological, and immunophenotypic patterns in Omani patients with de novo acute myeloid leukemia.
Udayakumar AM; Pathare AV; Al-Kindi S; Khan H; Rehmen JU; Zia F; Al-Ghazaly A; Nusrut N; Khan MI; Wali YA; Al-Lamki Z; Dennison D; Raeburn JA
Cancer Genet Cytogenet; 2007 Sep; 177(2):89-94. PubMed ID: 17854660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
